THE SPECIFIC FEATURES OF HEART AND VESSELS REMODELING IN PATIENTS WITH CHRONIC HEART FAILURE TREATED WITH LISINOPRIL DURING 6 MONTHS
Background. Being able to attenuate pathological remodeling, ACE inhibitors are considered to be first line medications for chronic heart failure (CHF) treatment.Aim. To study the influence of the 6-month combined therapy with lisinopril on the heart and vessels remodeling in patients with ischemic...
Saved in:
Main Authors: | N. A. Kosheleva, A. P. Rebrov |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2016-01-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/868 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Heart remodelling type role and effectiveness of lisinopril and bisoprolol therapy among patients with rheumatic mitral disease
by: T. A. Abdullaev, et al.
Published: (1970-01-01) -
LISINOPRIL USAGE IN CARDIOLOGIC PRACTICE: DATA OF EVIDENCE BASED MEDICINE
by: N. P. Kutishenko, et al.
Published: (2015-12-01) -
LISINOPRIL IMPLICATION IN THE CLINICAL PRACTICE
by: V. I. Podzolkov, et al.
Published: (2016-01-01) -
Measurement and Comparison of Costs of Hypertensive Patients Aged 40-89 Years Treated with Lisinopril and Perindopril
by: Joana Simeonova, et al.
Published: (2018-03-01) -
CARDIOPROTECTIVE PROPERTIES OF LISINOPRIL: NEW POSSIBILITIES
by: V. I. Podzolkov, et al.
Published: (2018-07-01)